Tech Company Financing Transactions
HemaQuest Pharmaceuticals Funding Round
HemaQuest Pharmaceuticals, based in San Diego, received $4 million from Latterell Venture Partners.
Transaction Overview
Company Name
Announced On
7/28/2010
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series B
Investors
Latterell Venture Partners (James Woody)
Proceeds Purpose
The financing will be used to help push HemaQuest's two lead drug candidates through mid-stage clinical trials designed to show they are safe and effective.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
11995 El Camino Real 302
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Longenecker
Chief Financial Officer
Tamara Seymour
Chief Medical Officer
Richard Ghalie
Browse more venture capital transactions:
Prev: 7/28/2010: Verient venture capital transaction
Next: 7/28/2010: Firefly LED Lighting venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs